Eli Lilly 2012 Annual Report Download - page 106

Download and view the complete annual report

Please find page 106 of the 2012 Eli Lilly annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 164

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147
  • 148
  • 149
  • 150
  • 151
  • 152
  • 153
  • 154
  • 155
  • 156
  • 157
  • 158
  • 159
  • 160
  • 161
  • 162
  • 163
  • 164

2
Proxy Statement Overview
Annual Meeting of Shareholders
The annual meeting of shareholders will be held at 11:00 a.m. EDT on Monday, May 6, 2013 at:
The Lilly Center Auditorium
Lilly Corporate Center
Indianapolis, Indiana 46285
The board of directors of Eli Lilly and Company, "we," "Lilly," or "the company," is soliciting proxies to be voted at
the annual meeting and at any adjournment of the annual meeting. The record date for voting is March 1, 2013.
Meeting Agenda
Shareholders will vote on the following items at the annual meeting:
Agenda
Item Management
recommendation Vote required
to pass
Item 1 Elect the following nominees for director to serve a three-year term that will expire in 2016: Vote FOR all Majority of
votes cast
Name and principal occupation Joined the board Age Public boards
Ralph Alvarez 2009 57 Lowe's
Companies, Inc.;
Dunkin' Brands
Group, Inc.
Vote FOR
Executive Chairman,
Skylark Co., Ltd.
Sir Winfried Bischoff 2000 71 The McGraw-Hill
Companies, Inc. Vote FOR
Chairman, Lloyds Banking Group plc
R. David Hoover 2009 67 Ball Corporation;
Energizer
Holdings, Inc.;
Steelcase, Inc.
Vote FOR
Chairman, Ball Corporation
Franklyn G. Prendergast, M.D., Ph.D. 1995 68 __ Vote FOR
Edmond and Marion Guggenheim Professor of
Biochemistry and Molecular Biology and
Professor of Molecular Pharmacology and
Experimental Therapeutics, Mayo Medical
School; and Director Emeritus, Mayo Clinic
Center for Individualized Medicine
Kathi P. Seifert 1995 63 Supervalu Inc.;
Revlon Consumer
Products
Corporation;
Lexmark
International, Inc.
Vote FOR
Retired Executive Vice President, Kimberly-
Clark Corporation
Item 2 Ratify the appointment of Ernst & Young LLP as the company’s principal independent
auditor. Vote FOR Majority of
votes cast
Item 3 Approve, by non-binding vote, compensation paid to the company’s named executive
officers. Vote FOR Majority of
votes cast
Item 4 Reapprove the material terms of the performance goals for the 2002 Lilly Stock Plan. Vote FOR Majority of
votes cast
Additional information about these agenda items can be found under “Items of Business” below. Information on
voting and attending the annual meeting can be found under “Meeting and Voting Logistics” below.
Board of Directors
The company’s board is comprised of our chairman, president, and CEO, John Lechleiter, Ph.D., and 13 independent
directors. Their biographies and qualifications can be found under “Director Biographies” below.
Committees of the board of directors
The board has six committees, all of which are staffed by independent directors. Additional information on the
functioning of the board and its committees, including director independence, can be found beginning in the section
titled “Highlights of the Company’s Corporate Governance Guidelines” below.